UNITY Biotechnology to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will participate in the following investor conferences in September.

Citi 17th Annual BioPharma Conference Format: One-on-one investor meetings Date: September 6 – 8, 2022Location: Four Seasons Hotel Boston, Massachusetts

H.C. Wainwright 24th Annual Global Investment Conference Format: Corporate update presentation and one-on-one investor meetingsDate and Time: Monday, September 12, 2022 at 4 PM ET Location: Virtual

A live webcast of the H.C. Wainwright presentation is available by clicking here and will also be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITYUNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.

Media Contact: Evoke CanaleJason Spark[email protected]

Investor Contact: Joyce Allaire LifeSci Advisors 212-915-2569 [email protected]

Source: Unity Biotechnology, Inc

Source: Unity Biotechnology, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Man Group PLC : Form 8.3 - Tyman plc
• Man Group PLC : Form 8.3 - Barratt Developments plc
• AGILITI ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of AGTI and Encourages Investors to Contact the Firm